Literature DB >> 17197619

Genetic alterations in thyroid cancer: the role of mouse models.

K A B Knostman1, S M Jhiang, C C Capen.   

Abstract

Thyroid carcinomas are the most common endocrine neoplasms in humans, with a globally increasing incidence. Thyroid follicular cells and neuroendocrine (parafollicular) C cells are each susceptible to neoplastic transformation, resulting in thyroid cancers of differing phenotypes with unique associated genetic mutations and clinical outcomes. Over the past 15 years, several sophisticated genetically engineered mouse models of thyroid cancer have been created to further our understanding of the genetic events leading to thyroid carcinogenesis in vivo. The most significant mouse models of papillary, follicular, anaplastic, and medullary thyroid carcinoma are highlighted, with particular emphasis on the relationship between the relevant oncogenes in these models and genetic events in the naturally occurring human disease. Limitations of each model are presented, and the need for additional models to better recapitulate certain aspects of the human disease is discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17197619     DOI: 10.1354/vp.44-1-1

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  13 in total

Review 1.  The genomic revolution and endocrine pathology.

Authors:  Suzana S Couto; Robert D Cardiff
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Single photon emission computed tomography imaging for temporal dynamics of thyroidal and salivary radionuclide accumulation in 17-allyamino-17-demothoxygeldanamycin-treated thyroid cancer mouse model.

Authors:  Yu-Yu Liu; Michael P Brandt; Daniel H Shen; Richard T Kloos; Xiaoli Zhang; Sissy M Jhiang
Journal:  Endocr Relat Cancer       Date:  2010-11-30       Impact factor: 5.678

3.  Anaplastic transformation of differentiated thyroid carcinoma.

Authors:  Gamal Khairy
Journal:  Int J Health Sci (Qassim)       Date:  2009-01

Review 4.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

5.  A novel orthotopic mouse model of human anaplastic thyroid carcinoma.

Authors:  Carmelo Nucera; Matthew A Nehs; Michal Mekel; Xuefeng Zhang; Richard Hodin; Jack Lawler; Vânia Nose; Sareh Parangi
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

6.  Drosophila Cancer Models Identify Functional Differences between Ret Fusions.

Authors:  Sarah Levinson; Ross L Cagan
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

7.  RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

Authors:  Giuliana Cassinelli; Enrica Favini; Debora Degl'Innocenti; Alessandro Salvi; Giuseppina De Petro; Marco A Pierotti; Franco Zunino; Maria Grazia Borrello; Cinzia Lanzi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

8.  PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.

Authors:  Carine Pestourie; Benoît Thézé; Bertrand Kuhnast; Stéphane Le Helleix; Karine Gombert; Frédéric Dollé; Bertrand Tavitian; Frédéric Ducongé
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

9.  An in vivo mouse model of metastatic human thyroid cancer.

Authors:  Lisa Zhang; Kelli Gaskins; Zhiya Yu; Yin Xiong; Maria J Merino; Electron Kebebew
Journal:  Thyroid       Date:  2014-03-10       Impact factor: 6.568

10.  The role of Cdk5 in neuroendocrine thyroid cancer.

Authors:  Karine Pozo; Emely Castro-Rivera; Chunfeng Tan; Florian Plattner; Gert Schwach; Veronika Siegl; Douglas Meyer; Ailan Guo; Justin Gundara; Gabriel Mettlach; Edmond Richer; Jonathan A Guevara; Li Ning; Anjali Gupta; Guiyang Hao; Li-Huei Tsai; Xiankai Sun; Pietro Antich; Stanley Sidhu; Bruce G Robinson; Herbert Chen; Fiemu E Nwariaku; Roswitha Pfragner; James A Richardson; James A Bibb
Journal:  Cancer Cell       Date:  2013-10-14       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.